Free Trial
NASDAQ:OPRX

OptimizeRx Q3 2025 Earnings Report

OptimizeRx logo
$21.68 +2.09 (+10.67%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$22.05 +0.37 (+1.71%)
As of 10/24/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OptimizeRx EPS Results

Actual EPS
N/A
Consensus EPS
$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

OptimizeRx Revenue Results

Actual Revenue
N/A
Expected Revenue
$23.83 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

OptimizeRx Announcement Details

Quarter
Q3 2025
Time
After Market Closes
Conference Call Date
Thursday, November 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

OptimizeRx Earnings Headlines

If You Keep Cash In A U.S. Bank Account… Read This NOW
The Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of customer deposits as Americans rush into a new form of money… That’s just been authorized under President Trump’s highly controversial new law, S.1582.tc pixel
OptimizeRx: How It Is Changing Pharma Marketing
See More OptimizeRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OptimizeRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your email.

About OptimizeRx

OptimizeRx (NASDAQ:OPRX), Inc. is a healthcare technology company that operates a digital health network designed to facilitate communication between pharmaceutical manufacturers, payers and healthcare providers. Through its cloud-based platform, OptimizeRx delivers targeted digital interventions—such as patient savings messages, clinical content and product information—directly into electronic health record (EHR) workflows at the point of care. By integrating with leading EHR systems, the company helps life sciences organizations optimize brand engagement, improve patient adherence and support informed prescribing decisions.

The company’s core offerings include digital prescription benefit notifications, co-pay assistance alerts and real-time clinical messaging tailored to specific patient populations. These tools allow pharmaceutical and biotechnology firms to deliver personalized messaging to physicians and care teams, ensuring that relevant formulary and financial support information is accessible at the moment of treatment. In addition, OptimizeRx provides data analytics and reporting capabilities that enable clients to measure the impact of their digital outreach and refine strategies to drive prescription growth and patient outcomes.

Founded in 2003 and headquartered in Cleveland, Ohio, OptimizeRx has formed partnerships with a broad spectrum of EHR vendors and health systems across the United States. The company’s network reaches tens of thousands of healthcare providers, making it one of the largest point-of-care communication platforms in the country. OptimizeRx collaborates closely with payers to integrate eligibility and benefit information, ensuring that savings offers and coverage details are accurate and up to date.

OptimizeRx is led by Chief Executive Officer David Whitlinger, who joined the company in 2019 and has overseen its expansion of digital service offerings and strategic alliances. Under his leadership, the company has focused on enhancing interoperability, scaling its network footprint and delivering advanced analytics to clients. While its primary market remains the U.S., OptimizeRx continues to explore opportunities to extend its digital health network into new regions and therapeutic areas.

View OptimizeRx Profile

More Earnings Resources from MarketBeat